(MENAFN- Ameliorate Digital Consultancy)
As per the study initiated by Evolve Business Intelligence, the global Sexually Transmitted Diseases (STD) Testing market size accounted for USD 25.5 Billion in 2022, growing at a CAGR of 6.1% from 2023 to 2033. The STD testing market encompasses a wide range of sexually transmitted infections, including but not limited to HIV/AIDS, chlamydia, gonorrhea, syphilis, herpes, and human papillomavirus (HPV). The market includes both laboratory-based tests performed in clinical settings and self-testing kits that can be used at home or in other non-clinical settings. The market for STD testing is driven by factors such as the increasing prevalence of sexually transmitted infections, the growing awareness of the importance of early detection and treatment, and the implementation of public health programs and initiatives to control the spread of STDs. Factors like changes in sexual behaviors, population demographics, and the availability of affordable and accessible testing options also impact the market. The market is influenced by technological advancements in diagnostic testing, such as the development of rapid and point-of-care tests that provide quick and accurate results. There is also a growing focus on molecular diagnostics and nucleic acid amplification tests (NAATs) for improved sensitivity and specificity in detecting STDs.
Request Free Sample Report or PDF Copy :
Key Highlights:
The global Sexually Transmitted Diseases (STD) Testing Market size was valued at USD 5 billion in 2022 growing at a CAGR of 6.1% from 2023 to 2033. North America dominated the market in 2022 Asia Pacific is expected to fastest-growing at the highest CAGR from 2023 to 2033
Evolve Business Intelligence has published a new market research report on Global Sexually Transmitted Diseases (STD) Testing Market focusing in various aspects including market size and forecast, market dynamics, competitors market share analysis, market size in terms of value and volume, SWOT analysis, product benchmarking, key players recent developments, and opportunities, among others. The market has also been analyzed based on 4 indicators in the market dynamic chapter which includes Drivers, Restraints, Key Trends, and Challenges. The overall sum of these sections will help to understand the best strategies to be adopted in order to prosper through this industry over short and long terms. The quantitative analysis includes our authentic findings out of this research study where we provided additional insight into what our readers can do to embrace new opportunities or plan against threats that might hinder the market.
In terms of COVID 19 impact, the Sexually Transmitted Diseases (STD) Testing market report also includes the following data points:
COVID19 Impact on Sexually Transmitted Diseases (STD) Testing market size End-User/Industry/Application Trend, and Preferences Government Policies/Regulatory Framework Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies Opportunity in Sexually Transmitted Diseases (STD) Testing market
Buy Latest Copy of Report Now at Higher Discount:
Key Players
Some of the major Sexually Transmitted Diseases (STD) Testing players holding high market share include Abbott laboratories, Becton Dickinson Company, BioMérieux, Inc., Bio-Rad Laboratories, Inc. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders.
The key players profiled in the report are:
Abbott laboratories Becton Dickinson Company BioMérieux, Inc. Bio-Rad Laboratories, Inc. Danaher Corporation Diasorin Molecular LLC Hologic, Inc. Orasure Technologies, Inc. Roche Holding AG Thermo Fisher Scientific Inc.
Segmental Analysis
Market Segment By Disease Type with focus on market share, consumption trend, and growth rate of Sexually Transmitted Diseases (STD) Testing Market:
Chlamydia Gonorrhea Herpes simplex virus Syphilis Human papillomavirus (HPV) Other diseases (human immunodeficiency virus (HIV), chancroid, trichomoniasis, and hepatitis B)
Market Segment By Location of Testing with a focus on market share, consumption trend, and growth rate of the Sexually Transmitted Diseases (STD) Testing Market:
Laboratory testing Point of care (POC) testing
| Parameters | Details |
| Market Size (2022) | $ 25.5 Billion |
| CAGR (2023 to 2033) | 6.1% |
| Market Segmentation | Disease Type, Location of Testing |
| Country Covered | US, Canada, Mexico, UK, Germany, France, Italy, Spain, Nordic Countries, BeNeLux, Rest of Europe, China, India, Japan, South Korea, Indonesia, Malaysia, Australia, Rest of Asia Pacific, Middle East & Africa, and South America |
For more information :
Global Sexually Transmitted Diseases (STD) Testing Geographic Coverage:
North America Europe UK Germany France Italy Spain Nordic Countries Benelux Rest of Europe
Asia Pacific China Japan India South Korea Indonesia Malaysia Australia Rest of Asia Pacific
Middle East and Africa Saudi Arabia UAE Egypt South Africa Rest of MEA
Latin America Mexico Brazil Argentina Rest of Latin America
Reasons to Buy this Report:
Detail analysis of the impact of market drivers, restraints, and opportunities Competitive Intelligence provides an understanding of the ecosystem Details analysis of the Total Addressable Market (TAM) of your products Investment Pockets and New Business Opportunities Demand-supply gap analysis Strategy Planning
About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.
Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email:
Website:
MENAFN02062023004660010643ID1106379971
Comments
No comment